Jiangsu CoWin Biotech Statistics

Total Valuation

SHA:688426 has a market cap or net worth of CNY 2.54 billion. The enterprise value is 1.97 billion.

Market Cap	2.54B
Enterprise Value	1.97B

Important Dates

The next confirmed earnings date is Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	n/a

Share Statistics

SHA:688426 has 109.93 million shares outstanding. The number of shares has decreased by -9.06% in one year.

Current Share Class	109.93M
Shares Outstanding	109.93M
Shares Change (YoY)	-9.06%
Shares Change (QoQ)	-0.72%
Owned by Insiders (%)	0.45%
Owned by Institutions (%)	11.68%
Float	34.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.18
PB Ratio	1.81
P/TBV Ratio	1.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.12
EV / Sales	10.23
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -7.13% and return on invested capital (ROIC) is -25.59%.

Return on Equity (ROE)	-7.13%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-25.59%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	8.75%
Revenue Per Employee	231,751
Profits Per Employee	-123,991
Employee Count	770
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-4.04M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.28% in the last 52 weeks. The beta is 0.83, so SHA:688426's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	-1.28%
50-Day Moving Average	25.53
200-Day Moving Average	24.98
Relative Strength Index (RSI)	31.72
Average Volume (20 Days)	1,165,204

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688426 had revenue of CNY 193.05 million and -103.28 million in losses. Loss per share was -0.94.

Revenue	193.05M
Gross Profit	193.05M
Operating Income	-104.79M
Pretax Income	-107.32M
Net Income	-103.28M
EBITDA	-76.38M
EBIT	-104.79M
Loss Per Share	-0.94

Full Income Statement

Balance Sheet

The company has 611.02 million in cash and 22.25 million in debt, with a net cash position of 588.77 million or 5.36 per share.

Cash & Cash Equivalents	611.02M
Total Debt	22.25M
Net Cash	588.77M
Net Cash Per Share	5.36
Equity (Book Value)	1.41B
Book Value Per Share	12.65
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -54.28% and -53.50%.

Gross Margin	100.00%
Operating Margin	-54.28%
Pretax Margin	-55.59%
Profit Margin	-53.50%
EBITDA Margin	-39.57%
EBIT Margin	-54.28%
FCF Margin	n/a

Dividends & Yields

SHA:688426 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	9.06%
Shareholder Yield	9.06%
Earnings Yield	-4.06%
FCF Yield	n/a

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 12, 2023. It was a forward split with a ratio of 1.2000048.

Last Split Date	Jun 12, 2023
Split Type	Forward
Split Ratio	1.2000048

Scores

Altman Z-Score	n/a
Piotroski F-Score	1